Indonesia · Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 25.74 trillion. The enterprise value is 29.47 trillion.
| Market Cap | 25.74T |
| Enterprise Value | 29.47T |
Important Dates
The next estimated earnings date is Thursday, October 23, 2025.
| Earnings Date | Oct 23, 2025 |
| Ex-Dividend Date | May 5, 2025 |
Share Statistics
IDX:HEAL has 15.37 billion shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | 15.37B |
| Shares Outstanding | 15.37B |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | -6.36% |
| Owned by Insiders (%) | 38.67% |
| Owned by Institutions (%) | 7.97% |
| Float | 8.31B |
Valuation Ratios
The trailing PE ratio is 59.70 and the forward PE ratio is 40.91. IDX:HEAL's PEG ratio is 2.88.
| PE Ratio | 59.70 |
| Forward PE | 40.91 |
| PS Ratio | 3.81 |
| PB Ratio | 3.67 |
| P/TBV Ratio | 4.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 24.41 |
| PEG Ratio | 2.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.17, with an EV/FCF ratio of -31.31.
| EV / Earnings | 70.57 |
| EV / Sales | 4.36 |
| EV / EBITDA | 17.17 |
| EV / EBIT | 32.13 |
| EV / FCF | -31.31 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.76 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | -3.83 |
| Interest Coverage | 4.03 |
Financial Efficiency
Return on equity (ROE) is 8.39% and return on invested capital (ROIC) is 5.97%.
| Return on Equity (ROE) | 8.39% |
| Return on Assets (ROA) | 5.26% |
| Return on Invested Capital (ROIC) | 5.97% |
| Return on Capital Employed (ROCE) | 8.92% |
| Revenue Per Employee | 376.10M |
| Profits Per Employee | 23.23M |
| Employee Count | 17,626 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 39.42 |
Taxes
In the past 12 months, IDX:HEAL has paid 185.87 billion in taxes.
| Income Tax | 185.87B |
| Effective Tax Rate | 25.91% |
Stock Price Statistics
The stock price has increased by +28.85% in the last 52 weeks. The beta is 0.19, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +28.85% |
| 50-Day Moving Average | 1,568.80 |
| 200-Day Moving Average | 1,415.05 |
| Relative Strength Index (RSI) | 53.73 |
| Average Volume (20 Days) | 16,057,860 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 6.76 trillion and earned 417.63 billion in profits. Earnings per share was 28.06.
| Revenue | 6.76T |
| Gross Profit | 2.13T |
| Operating Income | 917.19B |
| Pretax Income | 717.45B |
| Net Income | 417.63B |
| EBITDA | 1.71T |
| EBIT | 917.19B |
| Earnings Per Share (EPS) | 28.06 |
Balance Sheet
The company has 1.42 trillion in cash and 3.61 trillion in debt, giving a net cash position of -2,194.34 billion or -142.81 per share.
| Cash & Cash Equivalents | 1.42T |
| Total Debt | 3.61T |
| Net Cash | -2,194.34B |
| Net Cash Per Share | -142.81 |
| Equity (Book Value) | 7.01T |
| Book Value Per Share | 356.18 |
| Working Capital | 1.25T |
Cash Flow
In the last 12 months, operating cash flow was 1.05 trillion and capital expenditures -1,995.65 billion, giving a free cash flow of -941.27 billion.
| Operating Cash Flow | 1.05T |
| Capital Expenditures | -1,995.65B |
| Free Cash Flow | -941.27B |
| FCF Per Share | -61.26 |
Margins
Gross margin is 31.50%, with operating and profit margins of 13.56% and 6.18%.
| Gross Margin | 31.50% |
| Operating Margin | 13.56% |
| Pretax Margin | 10.61% |
| Profit Margin | 6.18% |
| EBITDA Margin | 25.29% |
| EBIT Margin | 13.56% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | 23.53% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 37.23% |
| Buyback Yield | -0.30% |
| Shareholder Yield | 0.33% |
| Earnings Yield | 1.62% |
| FCF Yield | -3.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
IDX:HEAL has an Altman Z-Score of 3.79 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.79 |
| Piotroski F-Score | 5 |